Sheba Medical Center, Israel
Michal Besser, PhD is the head of laboratory at The Ella Lemelbaum Institute for Immuno-Oncology and the director of the Wohl GMP facility at the Sheba Medical Center in Israel. Dr. Besser is an assistant professor at the Department of Clinical Immunology and Microbiology at Tel Aviv University. She completed her undergraduate studies and PhD at the University of Munich, Germany and her postdoctoral research at the Weizmann Institute of Science, Israel. The Besser lab is specialized in the clinical production of CAR T cells and Tumor Infiltrating Lymphocytes (TIL) for therapy of cancer patients. Adoptive cell therapy serves as a platform for a wide range of research projects, which mainly seek the understanding and improvement of cellular therapies and immunotherapy.